Sunday, November 02, 2025 8:04:32 AM
Since my preteens FACED scientific minded PhD’s
Sadly faced over a decade here of argumentative derision of clear one upmanship
and grandstanding by ALL the prolific high profile posters that devastated many hundreds of retirement accounts
NO different than what the populace hailed with NEIL WOODFORD the 10% NWBO Owner
https://en.wikipedia.org/wiki/Neil_Woodford?wprov=sfti1#Woodford_Investment_Management
Your concerned mother emailed me
Even LONGS here are non stop CONTENTIOUS SNIPERS
AND clearly have been way over their heads despite being DIEHARDS
Why it is a waste of time & effort to deal with SELF iNFLICTIONS!
DIFFERENT STROKES for DIFFERENT FOLKS
Sadly faced over a decade here of argumentative derision of clear one upmanship
and grandstanding by ALL the prolific high profile posters that devastated many hundreds of retirement accounts
NO different than what the populace hailed with NEIL WOODFORD the 10% NWBO Owner
On 15 October 2019 the fund board announced that Woodford's flagship fund, Woodford Equity Income Fund (WEIF), was to be shut down and Woodford had been removed as investment manager.[18] The following day Woodford announced he would resign from his remaining investment funds and close his investment company in an orderly fashion.[19] Around 300,000 people had invested in the WEIF, including 130,000 through the Hargreaves Lansdown investment site
Your concerned mother emailed me
Even LONGS here are non stop CONTENTIOUS SNIPERS
AND clearly have been way over their heads despite being DIEHARDS
Why it is a waste of time & effort to deal with SELF iNFLICTIONS!
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
